FY2024 EPS Estimates for Avantor Decreased by Zacks Research

Avantor, Inc. (NYSE:AVTR) – Zacks Research cut their FY2024 earnings per share (EPS) estimates for Avantor in a research note issued to investors on Friday, November 15th. Zacks Research analyst D. Dey now expects that the company will earn $0.98 per share for the year, down from their prior estimate of $1.01. The consensus estimate for Avantor’s current full-year earnings is $0.98 per share. Zacks Research also issued estimates for Avantor’s Q4 2024 earnings at $0.25 EPS, Q1 2025 earnings at $0.25 EPS, Q2 2025 earnings at $0.27 EPS, Q4 2025 earnings at $0.31 EPS, FY2025 earnings at $1.10 EPS, Q2 2026 earnings at $0.28 EPS and FY2026 earnings at $1.27 EPS.

AVTR has been the subject of several other reports. UBS Group cut their target price on shares of Avantor from $30.00 to $29.00 and set a “buy” rating for the company in a research report on Tuesday, October 8th. Stifel Nicolaus boosted their price objective on shares of Avantor from $27.00 to $28.00 and gave the company a “buy” rating in a research report on Monday, July 29th. TD Cowen raised their target price on Avantor from $28.00 to $31.00 and gave the stock a “buy” rating in a report on Monday, July 29th. Robert W. Baird cut their price target on Avantor from $27.00 to $26.00 and set an “outperform” rating for the company in a report on Monday, October 28th. Finally, Morgan Stanley upped their price target on Avantor from $28.00 to $29.00 and gave the stock an “overweight” rating in a research report on Monday, July 29th. Three investment analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. According to MarketBeat.com, Avantor currently has an average rating of “Moderate Buy” and a consensus price target of $27.57.

Avantor Trading Down 2.3 %

Avantor stock opened at $19.72 on Monday. The business has a 50-day simple moving average of $24.27 and a two-hundred day simple moving average of $23.94. Avantor has a 52-week low of $19.23 and a 52-week high of $28.00. The company has a quick ratio of 1.06, a current ratio of 1.54 and a debt-to-equity ratio of 0.84. The company has a market cap of $13.42 billion, a P/E ratio of 42.86, a P/E/G ratio of 2.52 and a beta of 1.35.

Insider Activity

In related news, CAO Steven W. Eck sold 3,525 shares of the stock in a transaction that occurred on Thursday, September 5th. The stock was sold at an average price of $25.06, for a total transaction of $88,336.50. Following the completion of the transaction, the chief accounting officer now directly owns 29,544 shares of the company’s stock, valued at approximately $740,372.64. This represents a 10.66 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 1.30% of the company’s stock.

Institutional Trading of Avantor

A number of large investors have recently added to or reduced their stakes in the company. Versant Capital Management Inc grew its holdings in shares of Avantor by 2,003.6% in the second quarter. Versant Capital Management Inc now owns 1,157 shares of the company’s stock valued at $25,000 after purchasing an additional 1,102 shares in the last quarter. Blue Trust Inc. grew its stake in shares of Avantor by 1,830.3% in the 2nd quarter. Blue Trust Inc. now owns 1,467 shares of the company’s stock worth $31,000 after buying an additional 1,391 shares in the last quarter. UMB Bank n.a. purchased a new position in shares of Avantor in the 3rd quarter worth $49,000. Nisa Investment Advisors LLC increased its holdings in shares of Avantor by 69.6% in the 3rd quarter. Nisa Investment Advisors LLC now owns 2,035 shares of the company’s stock worth $53,000 after buying an additional 835 shares during the last quarter. Finally, GAMMA Investing LLC raised its position in shares of Avantor by 89.9% during the 3rd quarter. GAMMA Investing LLC now owns 2,715 shares of the company’s stock valued at $70,000 after buying an additional 1,285 shares in the last quarter. Institutional investors own 95.08% of the company’s stock.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.